When Becky Quick announced the CNBC Cures initiative, our effort to raise awareness for rare diseases and improve the lives of the 30 million people living with them, we knew the response would be big. We didn’t know it would be this big. The response has been amazing, overwhelming and humbling.
Thank you for your interest — and for the outpouring of support for what we’re doing. The CNBC Cures mission is a personal one for me. Not just because I’ve spent the last several months helping to launch this platform — but because Becky’s story is mine too. Becky’s my sister. Kaylie’s my niece and my goddaughter. The fact that people care about this means a lot to both of us.
We’ve received hundreds of messages from groups asking how they can help support Cures, and we’ve heard from many companies interested in sharing their efforts in the rare disease space. But most importantly, we’ve heard from you. Our inboxes have been flooded with emails from viewers and readers who want to share their story… people who want to tell us about how their lives have been impacted by rare disease. In just the few days since we announced Cures, thousands have already signed up for the newsletter. We’ve also heard from people who just want to help us raise awareness of rare diseases, ask where they can send donations, or volunteer their time and support for the effort.
We appreciate all of it. We’re incredibly grateful for your interest in CNBC Cures. If you’d like to share your story or discuss opportunities on how you can be involved with CNBC Cures, email us at [email protected].
Keep the support coming. It’s proof that people care about rare diseases and that there’s an audience for this kind of content. We’re reading your messages, responding when we can and using them as inspiration for our stories.
Please tell your friends and family about CNBC Cures. Help us amplify our coverage around rare diseases. Let’s show the world that these issues matter.
